Herbert Lyerly
Corporate Officer/Principal presso Duke University
Patrimonio netto: - $ in data 31/03/2024
Posizioni attive di Herbert Lyerly
Società | Posizione | Inizio | Fine |
---|---|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - | - |
Storia della carriera di Herbert Lyerly
Precedenti posizioni note di Herbert Lyerly
Società | Posizione | Inizio | Fine |
---|---|---|---|
ONCOSEC MEDICAL INCORPORATED | Direttore/Membro del Consiglio | 17/04/2020 | 14/06/2023 |
Independent Dir/Board Member | 17/04/2020 | 14/06/2023 | |
Replicate Bioscience, Inc.
Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Fondatore | - | - |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Duke Comprehensive Cancer Center
Duke Comprehensive Cancer Center Duke Comprehensive Cancer Center develops outpatient bone-marrow transplantation program. The company is headquartered in Durham, NC. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Settori
Health Services | 2 |
Consumer Services | 2 |
Government | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ONCOSEC MEDICAL INCORPORATED | Health Services |
Aziende private | 3 |
---|---|
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Duke Comprehensive Cancer Center
Duke Comprehensive Cancer Center Duke Comprehensive Cancer Center develops outpatient bone-marrow transplantation program. The company is headquartered in Durham, NC. | |
Replicate Bioscience, Inc.
Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Herbert Lyerly
- Esperienza